Our team

oncgnostics GmbH has a R&D and a production department. Our lab team ist working on further improving the CE IVD marked GynTect assay, furthermore they are developing other assay systems (POCT, automation) and working on our pipeline projects on other cancer entities.

The whole company is working under a quality management system that is certified according to EN ISO 13485.

Kerstin Brox

Kerstin Brox

Economist - finances

Kerstin Brox is responsible for the Finance Department at oncgnostics GmbH. She is one of the co-founders of oncgnostics, and she has been part of oncgnostics GmbH since it was first dreamt up in 2010. 10 years of professional experience in the credit industry at a major bank, and several years as Procurement Manager at a major marketing agency in Jena, provided the ideal professional background.

Ines Sommer

Ines Sommer

Marketing and Communications

Ines Sommer is responsible for Marketing and Communications at oncgnostics since October 2018. After studying communication sciences (B.A.) and radio journalism (M.A.), Ines Sommer worked as a freelance journalist. Moreover, her job at a Leipzig PR agency has enabled her to understand both sides of the media industry.
She now brings her experience in corporate communications and marketing at a hospital into oncgnostics.

Dana Schmidt

Dana Schmidt

Pharma-Biotechnologist – QM Officer, Data Protection Officer, Assay Development

Dana Schmidt has been working at oncgnostics GmbH since October 2012. As Quality Management Officer, she is responsible for the establishment and ongoing development of the company’s own QM system, which has been certified according to ISO13485. As part of the development team, she also brought GynTect ® to market, drawing her research and development expertise from her many years working in the in-vitro diagnostics industry.

Kristina Wunsch

Kristina Wunsch

Biology Laboratory Technician – Research & Development

Kristina Wunsch, well-experienced biology laboratory technician with long-lasting academic and industry experience, has been part of oncgnostics GmbH since October 2012. She made and makes essential contributions to the further development of GynTect®, brings her experience into several R&D projects. Besides, she is responsible for laboratory organisation.

Anne Hengst

Anne Hengst

Biotechnologist – Development, Quality Control, Quality Management

Anne Hengst has joined oncgnostics in September 2013 and works since then in Research & Development, especially in assay development. With her strong molecular and bioinformatic background as well as the experience she has collected during development of GynTect® into a CE IVD product, she is an important member of the R&D team. Moreover, Anne heads Quality Control, and she is deputy QM Officer.

Dr. Juliane Hippe

Dr. Juliane Hippe

Biologist – Production Management

Juliane Hippe is part of the oncgnostics team since it’s formation, starting with her diploma thesis, continuing with her PhD thesis, both in the Gynaecological Molecular Biology working group of the gynaecology clinic of the Jena University Women’s Hospital. With both scientific projects she made important contributions to the scientific basis of oncgnostics’ first product: GynTect®. After completing her PhD with us, she fully joined the company. She is now mainly responsible for production control and monitoring as well as further development of the product GynTect®.

Kristin Knoll

Kristin Knoll

Pharma-Biotechnologist – Research & Development, Application Specialist, Customer Management

Kristin Knoll has been working in R&D at oncgnostics GmbH since June 2015, carrying out work on adapting GynTect® assays for extended applications. Already with her Master’s thesis at oncgnostics GmbH, she made an essential contribution to the development of GynTect®. She now is also responsible for customer management, and as an application specialist she advises and trains existing and potential customers in integrating GynTect® into their workflow.

Dr. Anne Hennig

Dr. Anne Hennig

Nutritionist – Research & Development, Project Management

Anne Hennig joined oncgnostics GmbH in April 2018, to strengthen Research and Development with her profound scientific background. Anne is responsible for the coordination of all R&D projects at oncgnostics. She is also in charge of projects that focus on further developing GynTect® (establishing point-of-care systems, automation). Anne Henning received her PhD in the field of molecular cell biology.

Anna-Bawany Hums

Anna-Bawany Hums

Molecular Biologist – Research & Development

Anna-Bawany Hums has been part of the oncgnostics GmbH team since May 2017. She is responsible for the development of pipeline products in the field of head and neck tumours. Her master’s thesis at the gynaecology clinic of the Jena University Women’s Hospital already focused on the detection of ovarian cancer using DNA methylation markers, another pipeline project at oncgnostics.

Carolin Dippmann

Carolin Dippmann

Pharma-Biotechnologist

Carolin Dippmann is currently finalizing her PhD thesis, for which she did her practical work at the Gynaecological Molecular Biology unit of the gynaecology clinic of the Jena University Women’s Hospital and at oncgnostics, with the subject: Biology of Markers – Methylation Analysis of GynTect® Markers in Different Stages and Precursors of Cervical Cancer. Since July 2020 she is full member of the oncgnostics team.

Theresa Erler

Theresa Erler

Pharma-Biotechnologist – Research & Development

Theresa Erler has fully joined oncgnostics in July 2019, and since then is active in the research and development sector. Theresa is part of the team working on pipeline products for head and neck cancer diagnostics. With her master’s thesis, which she completed at oncgnostics GmbH, she has already made important contributions to the head and neck tumour detection pipeline project.

Dr. Bettina Stieber

Dr. Bettina Stieber

Pharma-Biologist – Research & Development

Bettina Stieber works in Research and Development at oncgnostics since September 2019. Bettina is biologist and holds a PhD in Medical Microbiology with a focus on Point of Care Diagnostics which she already performed in the diagnostics industry and where she collected further professional experience before she joined oncgnostics. Bettina is involved in several projects, and is responsible for project management, together with Anne Hennig.